Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Expecting…well….whatever now.
Leeches ( shorters) in charge.
So there is unlikely to be stability or any meaningful upwards move.
But tbh…..I haven’t a clue what they will do. I suspect they will bring us down yet again but absolutely do not know.
They could buy back too.
But not to expect is imo healthy.
Like the previous poster, I’m just going to leave it all.
Bronte Capital Management declared and took a .50% short on 2nd December which was on Thursday
https://shorttracker.co.uk/company/GB00BJL5BR07/
We know that on Thursday the high was 68p we have 180m shares in issue so just stating the obvious that's 900,000 shares sold. WE don't know if Bronte Increased on Friday or if Renaissance Technologies are still short as they were at .49 previously just under the notification limit. No way could they sell those at the absolute high, so how far down do they think they can take this ?
I guess whilst we are in a news lull and Christmas around the corner these vultures will move in. These on top of Steven selling really hacks me off frankly.
The 900,000 of shares being sold into the market when share volume is low is going to affect the share price, it can't not but at least helps explain why when we get a bit of buying interest, the buys are being sold into.
The bottom line is that once the updates roll specifically the Q1 data we should move us materially higher. The data due this month for Asthma should also help. For me now i'm just going to lock away now and just ride it out.
What will be will be, GLA
Whilst the qualification criteria will vary (typically £50m to £250m for GBP stocks), a company with a £100m valuation would be considered to be a "micro-cap" stock, whereas say a company valued at £300m would still be considered a "small-cap" stock (£250m - £2bn or the bottom 20% of shares by Market Cap). Consequently there are very, very few Funds that would be allowed under their Trust Deeds to invest in such companies; even Smaller Companies Funds would often be precluded from investing in a company so small. So it is likely to be only specialist Biomedical, Healthcare or Ultra/Micro Cap Company Funds that would be free to invest in a company of this size; moreover FCA rules actually limit the proportion of a given fund's assets that can go into a single investment (if it is a "regulated" fund). Adding all this together the conclusion would have to be that only a very small %age of the total available investment Funds looking for a home would be targeting 4D Pharma.
Right now we have an Mcap of £100m let's say that the max that a fund could invest is £5m else they start to hit supply problems especially if more than one is trying to buy. That level of investment is too low for them to be concerned about, too low to do the research let's say it 10bagged, they'd make £50m, that's not actually an interesting amount of money for larger funds. They can't invest yet is my opinion.
So on the clinical trial website searching for 4d pharma it was showing 8 trials….there is actually 9 loaded on there it seems just waiting for website refresh to show what this is. Usually takes a working day or so
Even though 4d have left it very late in the year I'd be very surprised ?? if we didn't have at least one important piece of news this side of Christmas - it won't be re keytruda + 0518 trial. Management and DP in particular know that their credibility would receive a serious dent otherwise. Whatever that important piece of news is, they also know it has to be positive: they can't control the outcome of research of course but they can steer, to a large extent, commercial negotiations re Blautix to a successful outcome. After all, it is 4d that kept on saying how successful the phase II trial was, even before the result was announced.
Looking at it now against Nasdaq and biotech was just part of market throwing up Friday afternoon. Seres down 6% that’s all. Nasdaq at one point was well over 2% down but recovered bit into close.
Synairgen is a great example of that, there are others, we have discussed this on the SNG board some time ago in great lengths.
I didn't feel comfortable watching us drop into red yesterday... at a point where we are presumably awaiting material updates any day now. All kinds of scenarios were popping up in my head, involving leaks etc.
In reality, there is 101 reason someone might be selling. They could be under pressure from their creditors, need to balance books, have a redefined investment objectives, etc. Second guessing that is pointless.
I was relieved when there was no RNS yesterday morning, I support the 'Friday is a day for bad RNS' theory. We can just hope that selling yesterday was not due to anything out of the ordinary.
Good luck all holders.